Thermo Fisher Scientific Inc (TMO)
572.77
+1.04
(+0.18%)
USD |
NYSE |
Apr 26, 10:21
Thermo Fisher Scientific Debt to Equity Ratio: 0.7471 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.7471 |
| September 30, 2023 | 0.7784 |
| June 30, 2023 | 0.7773 |
| March 31, 2023 | 0.8343 |
| December 31, 2022 | 0.7842 |
| September 30, 2022 | 0.6696 |
| June 30, 2022 | 0.7155 |
| March 31, 2022 | 0.812 |
| December 31, 2021 | 0.8548 |
| September 30, 2021 | 0.5608 |
| June 30, 2021 | 0.5095 |
| March 31, 2021 | 0.5318 |
| December 31, 2020 | 0.6299 |
| September 30, 2020 | 0.6628 |
| June 30, 2020 | 0.7134 |
| March 31, 2020 | 0.6992 |
| December 31, 2019 | 0.5982 |
| September 30, 2019 | 0.5809 |
| June 30, 2019 | 0.6627 |
| March 31, 2019 | 0.6553 |
| December 31, 2018 | 0.6884 |
| September 30, 2018 | 0.6982 |
| June 30, 2018 | 0.7344 |
| March 31, 2018 | 0.8014 |
| December 31, 2017 | 0.8267 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.8903 |
| June 30, 2017 | 0.7501 |
| March 31, 2017 | 0.7832 |
| December 31, 2016 | 0.7719 |
| September 30, 2016 | 0.8732 |
| June 30, 2016 | 0.6653 |
| March 31, 2016 | 0.7186 |
| December 31, 2015 | 0.5842 |
| September 30, 2015 | 0.6385 |
| June 30, 2015 | 0.6781 |
| March 31, 2015 | 0.746 |
| December 31, 2014 | 0.7088 |
| September 30, 2014 | 0.7058 |
| June 30, 2014 | 0.754 |
| March 31, 2014 | 0.8498 |
| December 31, 2013 | 0.6222 |
| September 30, 2013 | 0.4326 |
| June 30, 2013 | 0.4502 |
| March 31, 2013 | 0.4563 |
| December 31, 2012 | 0.4607 |
| September 30, 2012 | 0.4887 |
| June 30, 2012 | 0.4327 |
| March 31, 2012 | 0.4366 |
| December 31, 2011 | 0.4673 |
| September 30, 2011 | 0.4695 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5095
Minimum
Jun 2021
0.8548
Maximum
Dec 2021
0.6907
Average
0.6992
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Fonar Corp | 0.0008 |
| XWELL Inc | 0.00 |
| ProPhase Labs Inc | 0.2077 |
| Applied DNA Sciences Inc | 0.00 |
| Veracyte Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 98.73B |
| Total Liabilities (Quarterly) | 51.88B |
| Shareholders Equity (Quarterly) | 46.74B |
| Current Ratio | 1.755 |
| Net Debt Paydown Yield | -0.56% |